Bank Of America Corp Immatics N.V. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Immatics N.V. stock. As of the latest transaction made, Bank Of America Corp holds 1,344 shares of IMTX stock, worth $10,187. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,344

Previous 44,724 96.99%

Holding current value

$10,187

Previous $519,000 97.11%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.93 - $12.92 $474,143 - $560,469	-43,380 Reduced 96.99%	1,344 $15,000
Q2 2024 Aug 14, 2024	BUY	$9.78 - $13.49 $141,624 - $195,348	14,481 Added 47.88%	44,724 $519,000
Q1 2024 May 15, 2024	BUY	$10.23 - $12.94 $289,488 - $366,176	28,298 Added 1454.91%	30,243 $317,000
Q4 2023 Feb 14, 2024	SELL	$7.36 - $10.89 $165,357 - $244,665	-22,467 Reduced 92.03%	1,945 $20,000
Q2 2023 Aug 14, 2023	SELL	$5.92 - $12.72 $328,358 - $705,527	-55,466 Reduced 69.44%	24,412 $281,000
Q1 2023 May 12, 2023	SELL	$6.74 - $9.44 $30,424 - $42,612	-4,514 Reduced 5.35%	79,878 $551,000
Q4 2022 Feb 10, 2023	BUY	$8.05 - $11.58 $168,929 - $243,006	20,985 Added 33.1%	84,392 $735,000
Q3 2022 Nov 14, 2022	SELL	$3.31 - $13.06 $28,591 - $112,812	-8,638 Reduced 11.99%	63,407 $634,000
Q2 2022 Aug 12, 2022	BUY	$6.0 - $9.37 $208,236 - $325,195	34,706 Added 92.95%	72,045 $627,000
Q1 2022 May 16, 2022	BUY	$6.64 - $12.85 $4,960 - $9,598	747 Added 2.04%	37,339 $298,000
Q4 2021 Feb 08, 2022	BUY	$10.81 - $14.38 $85,961 - $114,349	7,952 Added 27.77%	36,592 $491,000
Q3 2021 Nov 15, 2021	BUY	$11.58 - $15.46 $320,094 - $427,345	27,642 Added 2769.74%	28,640 $372,000
Q2 2021 Sep 13, 2021	BUY	$10.43 - $12.81 $10,409 - $12,784	998 New	998 $12,000

Others Institutions Holding IMTX

# of Institutions

101

Shares Held

75.8M

Call Options Held

238K

Put Options Held

727K

View Full List

About Immatics N.V.

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $578M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

More about IMTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Immatics N.V. Transaction History